FindTrial
Sign In

A clinical study to know the effect of Tumbipatra-Lodhra malahara on vitapa chedda wound healing in comparison with effect of povidine ointment.

A randomised clinical study to evaluate the efficacy of Tumbipatra-Lodhra malahara on Episiotomy wound healing in comparison with povidine iodine ointment.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/06/034349
Enrollment
100
Registered
2021-06-23
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O94- Sequelae of complication of pregnancy, childbirth, and the puerperium

Interventions

Intervention1: Tumbi Lodhra malahara: malahara will be applied locally on episiotomy wound after defecation, micturition and 6 hour interval for 7 days post partum. Control Intervention1: Povidine iod

Sponsors

Anuradha Brikeshchand Gupta
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Primiparous women with normal vaginal delivery with episiotomy. investigations for inclusion- hemogram, HIV, HBSAG, VDRL, BSL-R

Exclusion criteria

Exclusion criteria: Women with any acute(PPH, Laceration, hematoma) OR chronic disease(DM, cardiac disease, Carcinoma, skin disease, GDM, any vaginal lesion, varicosity of vein or any immune compromised illness, STD)

Design outcomes

Primary

MeasureTime frame
To study the efficacy of Tumbi-Lodhra Malahara on episiotomy wound healing, in comparison with Povidine ointmentTimepoint: postpartum day 1 to day 8—

Secondary

MeasureTime frame
To study the adverse effect of Tumbi Lodhra malahara. To study details of wound, its care and healing.Timepoint: 14 months of study period—

Countries

India

Contacts

Public ContactProf Dr Manda Sanjog Ghorpade

Sumatibhai Shah Ayurved Mahavidyalay

mandaghorpade@yahoo.com9822007570

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026